{"name":"SCM Lifescience Co., LTD.","slug":"scm-lifescience-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxPVnZGYTBfR3o4czAtRFJXU1dwX190aXBvd3dCVUhxUnZXekRSeDR1TmN4ZkpHZWhVSlVBcWNVNXlXYmVQamUzWm9UR0hfY0pkaDNzV0NPdGV1aXFDREEzTGZTOUk0aEppbk9GUGs5b3R6MGdOOHR4djRLTkh2OW1Ub2t0dGh6SUV5VEctOFpOTzRHb05OSmRSVUQzRjhOOEZpZ3hfQ1hONzk0dm9xeEZqeTczSFBoWjllakRONGEzRzI1RDAxMlF6NmM3b0JYajJBWG1oU3dPczFZTkt6a3ZFeU5ER1pkZ0t6S21KVnUzVjhfRV9qRGJNb01HNkVUSVNIV0pmdEU4YU9fcGJBWmU0?oc=5","date":"2026-02-16","type":"pipeline","source":"PR Newswire","summary":"Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight - PR Newswire","headline":"Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | Delve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQdEFnQktFM210eXdiZmRhVlE4Y3FUTndfak5Cell5OFgyR1Z1QWxsaks4TzU0NTBvZlJIc0o3enpwWTlTYXBFR3o4eFZNZUg2QUpEZGN5Z3ZsTFRqTmZOMVBSZVpoa1YxT3ZHbFlaVVJOZHBWZjFkSE1jSFpXSVVpYVl2U1VhSHRJS1daVHZkSHAtLW5nbW1aeWZIZk9CQUxLNnVlYVF6VVZNRVdtT3ZpVzhMVkI1ODFPLUpqLWpBU3dEVnpWSldBX1JaTmZaX1VTUFJEc0hubWtXZGVwWmw4UmlyLUpTbk5MYVhCRENwaVByRVhzZXhobF9wUGJNYzUtMGNzWEFqbkN3enFKdFplVjJnYzVPQVduMDAzZ1Jn?oc=5","date":"2025-12-08","type":"regulatory","source":"globenewswire.com","summary":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma - globenewswire.com","headline":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxNbURGeFBVM19lWjJINGlwR01HamQ5X2traTA5bllxU0gyWkd6M21MeElyZXhHTzR2LUhvZ0tsbmNzZXVoVFp0bTc0a1pNZmxDaDFNTkxXT2RWNVpYZG5CZWpBYWNGNTVPVUVGQzJwYUY2YWpTb2hWMGJDSU5tUE9OMmlHOHNScHZDM3ZZRE5YXzFRTXZzT1BkYVFKWUlNN2g1YTh1aHJKN1h3eTJ2cTFFdzdVbnVHV05EWDQ0SVB6VEZDOFdkQzU2QUhyQXRXT3BmbDY0eDllY0R6LUhNaHo0dkU0dWtNUjJ5OGFteEdSUzM4SWlZVVRnX2ZDUWFMZmRKVmZXRllhZDNHN3QzLVRabWZERlhTV0JCTWdaQ1JUdmpqbkY5OHpNb053SUdRUQ?oc=5","date":"2025-10-23","type":"trial","source":"globenewswire.com","summary":"Hidradenitis Suppurativa Clinical Trial Analysis: Key - globenewswire.com","headline":"Hidradenitis Suppurativa Clinical Trial Analysis: Key","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9vRmJsZ1NIQ2dWRGJZQ0JNakc2ckxpYjVod2x3RXNIN1Q3Y3c0Q0VrSVdGR0tQd2VXbzlScm9yeXd6Vl9DR1duZjNZTkRvWTNtSXlldmVrbmY3SHhuMEFLNjAzNWRGckhWaUwtZWpUWlM2cVFlUUpiWkNqTDg?oc=5","date":"2025-10-15","type":"pipeline","source":"BioCentury","summary":"Pruzanski named CEO of Alentis - BioCentury","headline":"Pruzanski named CEO of Alentis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQd3FBTE9tSFhFOG1MMTJyZDNuSFc4aHdYY1paY0RYN0pGdXdKZF9KMG9XdWJoS3d6QnFjTVF3QUhBTjZYcEV6TEdrUUREcjF0Sjk0TTIwbzF3UDN3bk9BNmpPSGh1bEhRMmJRTUxJM0s0T3lKeEFTcVFGSVVqbTVoT1EzbzhpdVhzOUtldW8wTmtUdw?oc=5","date":"2025-05-20","type":"trial","source":"Yahoo Finance","summary":"Moderate to Severe Atopic Dermatitis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight - Yahoo Finance","headline":"Moderate to Severe Atopic Dermatitis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOSkFOUFNlZC1BR0tYYkdSdGdWREZHMGZPR1d3U2J5czVzMFZhX0N4SFhkcWw5V3pfS3BvSzNsZGdFRElyUGkxd1RyREd1SkJ0X2FVSy1tZW94OHdWclVBTlNkMy1TSWlQNE9IUGRSQnJaazZ6U1FrYUQ1bFYzNUFLdkZ5djdFXzZyd0RlQldLWlIxc3daNXAtMjNzbG5xWklRd1hUMkM5S29VZUxrSkRCUlY3eHN2SzB5YndTRG1aQ05CMVZ6Wlg2Z2oweE9uVWlkNVk1Q01Dd0pRcXhrb2p3ZXJ1cFJqRFJsbWllWU1rbURVOWFYU0R6bm0yVXg?oc=5","date":"2025-05-12","type":"trial","source":"PR Newswire","summary":"Chronic Pruritus Market is Anticipated to Expand at a CAGR of 8.6% During the Study Period (2020-2034) | DelveInsight - PR Newswire","headline":"Chronic Pruritus Market is Anticipated to Expand at a CAGR of 8.6% During the Study Period (2020-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPN25wOWkzelQzRHE2OERfdDZYNGhCWElLanZmTkZ3Z0h3WmJoLUw5UlQ1c2hZb1RibUJlVTZVQ1hEMWVzS19ja0xyeXhjZUR0ZF9BYUZiYnliUFZRVlR1ZmZOUmtLbjVnbHEyWGw2YTZVd0pFRzNReE5tZFhPTTcySW5qTHp0RjlnakFyV2kyWEs4ME5xT2ZqOVZrbVY3U2M4ZzV0UlhKQVotMl9wdHg0TEdRckZEdFE?oc=5","date":"2023-10-18","type":"deal","source":"BioWorld News","summary":"GI Innovation inks second GI-301 licensing deal with Japan’s Maruho for $220M - BioWorld News","headline":"GI Innovation inks second GI-301 licensing deal with Japan’s Maruho for $220M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNYi05QmdYVUJ3akthWnJ4UFF5eFl0cnFPUjdMblNKQjBiTXl5T1g2bk9wZ0VNRG9IMzNOMlAyVzZIQjhfTGYwcXVINzJjUUMzYnRoR0ZWT2lMY21RN2NPZ2hLZE1FZDYtZ1dwekRhNk9CMXJwZWdJdm9OaWU1V0dtdkYxdUF0Y3lMVUYyVHladm0?oc=5","date":"2022-12-05","type":"pipeline","source":"Yahoo Finance","summary":"Atopic Dermatitis Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Yahoo Finance","headline":"Atopic Dermatitis Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working in the Therapeutics Segment | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPemo2eUhJOVNYQ182anNrUm1MLVpBS0dkS3BfNURvZFZMcWRXZlduZVN4azlBdnNJVjVyYWhWNDhJWnhtYTRsdlIxdUpfYmZVc2czUGJuMVRHV3ZMRUM0enBtcGh0SG53ZkotMzE5UDllZm8xbW1JOU1KcXI4X0FYdTRhWkR2VUlydlg0b3lrTQ?oc=5","date":"2022-08-01","type":"pipeline","source":"Allied Market Research","summary":"mRNA Vaccine & RNAi Therapeutics Market Size, Growth | 2031 - Allied Market Research","headline":"mRNA Vaccine & RNAi Therapeutics Market Size, Growth | 2031","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNcXdCbkstZGxTQmVxeGhMcEhQZDJCWGpscjIxOVpodERHcWJxSGdVT0Nabm1zTGVwejhWZU5Cb1lKX25FZjRPNUtxRHNQMTVXTEZ0S284VThPbEtpTjBHcVhvai03U19lZlF1dEtOSTVxSmZWN3V4dkw0NFZZTnVraXlqcG5LcmFpZWJ2UXEyTXdSd2ZvMXBBZUtNUVYtS2llV3FUQU9RdTVRWlRZZXpxMWhsajB3RmtDbWNmdXdRVU9RS3VKUC16OVVfY3ctWklrdFVXVE1FUV81Vl8yMVNfSTFJanNySWJFMDRRMjJTX3paOFBRQncyTg?oc=5","date":"2022-03-04","type":"pipeline","source":"Business Wire","summary":"GI Innovation Recruits Chief Executive Officer Byung-Geon Rhee Former CEO of GC Pharma, SCM Lifescience Corp. - Business Wire","headline":"GI Innovation Recruits Chief Executive Officer Byung-Geon Rhee Former CEO of GC Pharma, SCM Lifescience Corp.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOckNPSF91U0hYcDlrTzBBdkFiZEtTX2REaDVqUnZQYTZuTlczQnN5RWxHUFFTTmNIamlNS0o5SHJIaTNMdWRRRVFfR2ZGZDlpeDFHTDhkcVh2VFVLZmxhWnJQdHdIOENrVVNQV2t1akVMb2NyWjkwdWRIOTRETXctd1B0c0zSAYoBQVVfeXFMTUViQWlqbzhZQTFPLUotc1RCOGpJSDA2a2o0V2FDSURwRjZ6eU5aelJOaGwtelFwRW1jNkhMU3RXT1NyeDU4WHlqMjJaNlJGSktXZmhJVFhVaVRsejhacHpTV1luZHpXbXdaMkR0VTgyR0dOaFZyeDNpWnVHZDNkV04tdEFUaWNhbDdn?oc=5","date":"2020-10-13","type":"deal","source":"BioInformant","summary":"Steminent Biotherapeutics licenses rights to SCM Lifescience to develop Stemchymal® cell therapy for treating spinocerebellar ataxia (SCA) in South Korea - BioInformant","headline":"Steminent Biotherapeutics licenses rights to SCM Lifescience to develop Stemchymal® cell therapy for treating spinocereb","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTFBfRTJrbGVHVkdXWFI1TmJwdjhvelZ3T2pBaWJvTEVGaGRKLV83THFEaGlzTGdLRkNvMHR2VERmMlFZM21CdHJkMzdadkFjcUFLNGdxeGRoSDltZHpOOFhjUmFJMkROUQ?oc=5","date":"2018-10-11","type":"deal","source":"University of Utah Health Academic Medical Center","summary":"SCM Lifescience and University of Utah Announce Multi-Year Research Collaboration to Advance New Allogenic Off-the-Shelf Cell Sheet for Regenerative Medicine - University of Utah Health Academic Medic","headline":"SCM Lifescience and University of Utah Announce Multi-Year Research Collaboration to Advance New Allogenic Off-the-Shelf","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}